Fujifilm Owns Japanese Drug Company Offering Influenza Drug As Potential Ebola Treatment
The New Yorker: How Fujifilm Came to the Ebola Fight
“…Japan said that Fujifilm was offering up the drug, Favipiravir, [which is made by Toyama Chemical, a company Fujifilm acquired five years ago,] as a potential stopgap in the fight against an outbreak of Ebola that has, according to the World Health Organization, killed nineteen hundred people in West Africa, and that Médecins Sans Frontières just called for a global military and civilian response to stop…” (Hunt, 9/5).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.